Eyes Down For Reckitt Benckiser Group Plc’s Results

We’ll see how Reckitt Benckiser Group Plc (LON: RB) fared in 2013.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Reckitt Benckiser Group (LSE: RB) (NASDAQOTH: RBGLY.US) shares have had a mixed ride — they’re up around 11% over 12 months to 4,656p, against a 3% rise for the FTSE 100, but it’s been a bit volatile.

The company was seen as something of a safe haven back in recession time, and its earnings were going strong — in 2009, we saw a 24% rise in earnings per share (EPS). But that growth has been slowing, down to just 7% by 2012. And analysts are actually expecting a modest fall of 1% for the year just ended in December 2013, with the same penciled in for 2014.

Results next week

Whether they’re right is something we shall find out on Wednesday 12 February, when we’ll have those 2013 results. But how has the year been going so far?

In third-quarter results released in October 2013, the owner of an array worldwide consumer brands reported like-for-like revenue growth of 5% for the quarter and the same for the year-to-date, excluding its pharmaceuticals business (RBP). Chief executive Rakesh Kapoor told us that the firm’s focus on health and hygiene and emerging markets was “delivering good results“.

And of RBP, he said “…we are commencing a strategic review of the business and will consider all options for maximising value for our shareholders. We expect the review to take some time and will update shareholders during the course of 2014“.

Prospects?

What of the full-year? Well, Mr Kapoor used that nasty “challenging” word when describing market conditions, but predicted full-year revenue growth of at least 6% with margins expected to be maintained.

Looking back further, statutory first-half EPS reported in July 2013 dropped 14% to 90.4p, though the company claimed a 7% rise to 118.3p for adjusted EPS. Like-for-like revenue at the time was up 6%, excluding RBP, with adjusted operating profit up 2% (though statutory operating profit fell 17%).

Looking at the spread of analysts’ opinions in the light of the year so far, I think Reckitt Benckiser’s 2013 EPS could be anywhere in a range of a few percent down to a few percent up.

Dividends

But what about dividends? Reckitt Benckiser traditionally provides a fairly average annual yield of a little over 3%, though it did rise a bit above that in the past couple of years as the share price fell back a little.

There’s a modest 3% rise in the 2013 dividend expected, to take it to about 138p per share for a yield of 3%. But the first-half dividend was lifted by 7% to 60p per share, so if anything that could be a bit conservative — in fact, the most recent forecasts are suggesting around 140p per share.

> Alan does not own any shares in Reckitt Benckiser.

More on Investing Articles

Shot of an young mixed-race woman using her cellphone while out cycling through the city
Investing Articles

Why I’m not buying tech growth shares… yet

History suggests growth shares can underperform when times get tough. Here's why Ken Hall is sticking with dividend shares for…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

£1,000 buys 2,500 shares in this fast-growing FTSE company that’s helping the UK government with AI

This 40p FTSE stock could do well as the UK government scrambles to update its out-of-date tech systems, says Edward…

Read more »

Man riding the bus alone
Investing Articles

As the FTSE 100 nears 11,000, these top shares are still dirt cheap!

These FTSE shares aren't without risk. But at current prices, our writer Royston Wild thinks they're too good to ignore.…

Read more »

BUY AND HOLD spelled in letters on top of a pile of books. Alongside is a piggy bank in glasses. Buy and hold is a popular long term stock and shares strategy.
Investing Articles

What are the best FTSE 100 shares to consider buying for the next 5 years?

When picking FTSE 100 shares for the long term, Edward Sheldon follows Warren Buffett’s playbook and focuses on growth and…

Read more »

Family in protective face masks in airport
Investing Articles

£10,000 invested in Diageo and Rolls-Royce shares just 1 week ago is now worth…

Diageo and Rolls-Royce shares headed in totally different directions last week. Which FTSE 100 stock looks worth considering today?

Read more »

Diverse children studying outdoors
Growth Shares

I asked ChatGPT which growth stocks to put in my ISA and it gave me this surprising answer…

Jon Smith explains why ChatGPT didn't give him the best advice when it came to picking growth stocks, but outlines…

Read more »

A front-view shot of a multi-ethnic family with two children walking down a city street on a cold December night.
Investing Articles

£5,000 in this FTSE 250 leisure stock could generate £260 in passive income

Down 26%, this well-known company from the FTSE 250 index is offering attractive passive income, with a dividend yield above…

Read more »

A couple celebrating moving in to a new home
Investing Articles

Are £21 BAE Systems shares still undervalued?

BAE Systems shares hit the £21 mark for the first time recently. But could they still be a cheap buy…

Read more »